(3aR-trans)-5-Chloro-2,3,3a,12b-tetrahydro-2-Methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-13C,d3 β-D-Glucopyranosiduronic Acid
![(3aR-trans)-5-Chloro-2,3,3a,12b-tetrahydro-2-Methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-13C,d3 β-D-Glucopyranosiduronic Acid price.](/CAS/GIF/1391745-10-0.gif)
|
- $225 - $2800
- Product name: (3aR-trans)-5-Chloro-2,3,3a,12b-tetrahydro-2-Methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-13C,d3 β-D-Glucopyranosiduronic Acid
- CAS: 1391745-10-0
- MF: C23H24ClNO7
- MW: 461.89216
- EINECS:
- MDL Number:
- Synonyms:(3aR-trans)-5-Chloro-2,3,3a,12b-tetrahydro-2-Methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-13C,d3 β-D-Glucopyranosiduronic Acid;Asenapine-13C,d3 N-β-D-Glucuronide;Asenapine-13C,d3 N-β-D-Glucuronide Trifluoroacetic Acid Salt
2 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 1mg
- 10mg
- ManufacturerMedical Isotopes, Inc.
- Product numberCD53977
- Product descriptionAsenapine-13C,d3N-β-D-GlucuronideTrifluoroaceticAcidSalt
- Packaging10mg
- Price$2800
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA788007
- Product descriptionAsenapine-13C,d3N-β-D-GlucuronideTrifluoroaceticAcidSalt
- Packaging1mg
- Price$225
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | CD53977 | Asenapine-13C,d3N-β-D-GlucuronideTrifluoroaceticAcidSalt | 10mg | $2800 | 2021-12-16 | Buy |
| TRC | A788007 | Asenapine-13C,d3N-β-D-GlucuronideTrifluoroaceticAcidSalt | 1mg | $225 | 2021-12-16 | Buy |
Properties
Melting point :>150°C (dec.)
storage temp. :Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :Off-White
storage temp. :Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :Off-White
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|